StockData
CVS HEALTH Corp logo

CVS HEALTH Corp

CVSNYSERetail-Drug Stores and Proprietary StoresFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 5, 2026Score 12/3016% above fair value
$88.51−1.74 (-1.93%)

Close on Nov 2, 2026Market cap $113.20BP/E 23.5Yield 3.01%

Cvs Health Medicare Part D Standalone Prescription Drug Plan by Year

Medicare Part D Standalone Prescription Drug Plan (PDP) Membership

Cvs Health Medicare Part D Standalone Prescription Drug Plan: 4,041.00K in FY2025, down 17.2% from a year earlier. That is the lowest of the 8 years on record here.

Latest, FY2025
4,041.00
Period ended Dec 31, 2025
Change on a year earlier
-17.2%
4,882.00 in FY2024
History
8 years
Since FY2018
Sources
8
Documents cited below

Where the FY2025 figure comes from

“|| Medicare Prescription Drug Plan (stand-alone) | 3,870 | 3,889 | 4,041 | 4,065”

Source: CVS Health 10-Q (2026-08-05) ↗

Supplemental standalone Medicare Part D PDP membership (SilverScript / Aetna).

Annual history

Hover a value to see the sentence it was read from; calculated values show their formula

PeriodEndedMedicare Part D Standalone Prescription Drug Plan (PDP) MembershipYear on yearSource
FY2025Dec 31, 20254,041.00-17.2%CVS Health 10-Q (2026-08-05) ↗
FY2024Dec 31, 20244,882.00-19.7%CVS Health 10-K (2026-02-10) ↗
FY2023Dec 31, 20236,081.00-0.8%CVS Health 10-K (2025-02-12) ↗
FY2022Dec 31, 20226,128.00+6.1%CVS Health 10-K (2024-02-07) ↗
FY2021Dec 31, 20215,777.00+5.2%CVS Health 10-K (2023-02-08) ↗
FY2020Dec 31, 20205,490.00-8.4%CVS Health 10-K (2022-02-09) ↗
FY2019Dec 31, 20195,994.00-2.3%CVS Health 10-K (2021-02-16) ↗
FY2018Dec 31, 20186,134.00–CVS Health 10-K (2020-02-18) ↗

Cite this data

StockData. (2026). Cvs Health Medicare Part D Standalone Prescription Drug Plan, annual FY2018–FY2025 [Data set]. Compiled from Cvs Health SEC filings and investor materials. https://stockdatahq.com/stocks/cvs/kpis/hcb-mem-pdp

See every metric in the Cvs Health KPI table. Data updated Oct 28, 2026.